All-Cause Mortality in People With Four-Class Drug-Resistant HIV: A Matched Cohort Analysis With Data From the PRESTIGIO Registry
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciaf421 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Andrea Giacomelli und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Clinical Sciences, Università Degli Studi di Milano, Milan, Italy. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents, Drug Resistance, Viral, Drug Resistance, Multiple, Viral. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ViiV Healthcare, Gilead Sciences, Merck Sharp & Dohme.
Abstract (Originalsprache)
People with human immunodeficiency virus (HIV) (PWH) with 4-drug class resistance (4DR) had a higher risk of death than non-4DR PWH, primarily due to lower CD4 cell counts. The priority for this vulnerable population is achieving virological control to enable immune recovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical and Clinical Sciences, Università Degli Studi di Milano, Milan, Italy.
- III Infectious Diseases Unit, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
- IRCCS Ospedale San Raffaele, Infectious Diseases Unit, Milan, Italy.
- Immunodeficiency Unit, National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Rome, Italy.
- Department of Medical and Surgical Sciences, Unit of Infectious Diseases, S. Orsola Hospital, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Infectious Diseases Unit, Agostino Gemelli; University Hospital, Rome, Italy.
ORCID-Profile: Andrea Giacomelli, Nicolò Capra, Tommaso Clemente, Giulia Marchetti, Vincenzo Spagnuolo
Förderung
- ViiV Healthcare
- Gilead Sciences
- Merck Sharp & Dohme
- Janssen-Cilag
- PRESTIGIO registry
- Janssen–Cilag
Zitieren
APA
Giacomelli, A., Capra, N., Lolatto, R., Gagliardini, R., Clemente, T., Calza, L., Torti, C., Lagi, F., Fornabaio, C., Marchetti, G., Orofino, G., Spagnuolo, V., & for PRESTIGIO Study Group (2025). All-Cause Mortality in People With Four-Class Drug-Resistant HIV: A Matched Cohort Analysis With Data From the PRESTIGIO Registry. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf421
Vancouver
Giacomelli A, Capra N, Lolatto R, Gagliardini R, Clemente T, Calza L, et al. All-Cause Mortality in People With Four-Class Drug-Resistant HIV: A Matched Cohort Analysis With Data From the PRESTIGIO Registry. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf421
BibTeX
@article{Giacomelli2025,
author = {Giacomelli, Andrea and Capra, Nicolò and Lolatto, Riccardo and Gagliardini, Roberta and Clemente, Tommaso and Calza, Leonardo and Torti, Carlo and Lagi, Filippo and Fornabaio, Chiara and Marchetti, Giulia and Orofino, Giancarlo and Spagnuolo, Vincenzo and for PRESTIGIO Study Group, for PRESTIGIO Study Group},
title = {All-Cause Mortality in People With Four-Class Drug-Resistant HIV: A Matched Cohort Analysis With Data From the PRESTIGIO Registry},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciaf421}
}
EUVIMED